Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C

Journal of Hepatology

Volumn 31, Issue 5, 1999, Pages 808-814

  Boya, Patricia ^a   Peña, Andrés De La ^a   Beloqui, Oscar ^a   Larrea, Esther ^a   Conchillo, Marian ^a   Castelruiz, Yurdana ^a   Civeira, María Pilar ^a   Prieto, Jesús ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Dept Int Med Liver U Univ C   (Spain)

Author keywords

Antioxidant enzymes; Glutathione; Hepatitis C virus; Malondialdehyde; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INTERFERON; LIVER ENZYME; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUTATHIONE METABOLISM; HEPATITIS C; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LYMPHOCYTE FUNCTION; MALE; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; VIRUS PATHOGENESIS;

EID: 0344631690     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80281-5     Document Type: Article

References (46)

1. Meister A, Anderson M. Glutathione. Ann Rev Biochem. 52:1983;711-760.
2. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, et al. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8:1994;1131-1138.
3. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Ann Rev Immunol. 15:1997;151-169.
4. Rushmore TH, Pickett CB. Glutathione S-transferases: structure, regulation, and therapeutic implications. J Biol Chem. 268:1993;11475-11488.
5. Sies H. Strategies of antioxidant defense. Eur J Biochem. 215:1993;213-219.
6. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 249:1974;7130-7139.
7. Spitz DR, Sullivan SJ, Malcolm RR, Roberts RJ. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radic Biol Med. 11:1991;415-423.
8. Koziel MJ. Immunology of viral hepatitis. Am J Med. 100:1996;98-109.
9. De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med. 21:1996;291-295.
10. Farinati F, Cardin R, De Maria N, Della-Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
11. Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 23:1996;1468-1475.
12. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol. 50:1997;401-406.
13. Beloqui O, Prieto J, Suárez M, Gil B, Qian CH, García N, et al. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res. 13:1993;279-282.
14. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology. 18:1993;1050-1054.
15. Bronowicki JP, Loriot MA, Thiers V, Grignon Y, Zignego AL, Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology. 28:1998;211-218.
16. Larrea E, Beloqui O, Muñoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med. 24:1998;1235-1241.
17. Sarobe P, Jauregui JI, Lasarte JJ, Garcia N, Civeira MP, Borrás-Cuesta, et al. Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment. J Hepatol. 25:1996;1-9.
18. Lasarte JJ, García-Granero M, López A, Casares N, García N, Civeira MP, et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology. 28:1998;815-822.
19. Gavier B, Martinez-González MA, Riezu-Boj JI, Lasarte JJ, García N, Civeira MP, et al. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology. 113:1997;1647-1653.
20. Larrea E, García N, Qian C, Civeira MP, Prieto J. Tumor necrosis alpha gene expression and response to interferon in chronic hepatitis C. Hepatology. 23:1996;210-217.
21. Schreiber C, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucleic Acids Res. 17:1990;6419-6422.
22. Castilla-Cortázar I, García M, Muguerza B, Quiroga J, Pérez R, Santidrián S, et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology. 113:1997;1682-1691.
23. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 196:1991;143-151.
24. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 27:1969;502-522.
25. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, Potter DW. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem. 106:1980;55-62.
26. Fariss MW, Reed DJ. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol. 143:1987;101-109.
27. Fernández-Checa JC, Kaplowitz N. The use of monochlorobimane to determine hepatic GSH levels and synthesis. Anal Biochem. 190:1990;212-219.
28. Gipp JJ, Chang C, Mulcahy RT. Cloning and nucleotide sequence of a full-length cDNA for human liver gamma-glutamylcysteine synthetase. Biochem Biophys Res Commun. 185:1992;29-35.
29. Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
30. Camussi G, Albano E, Tetta C, Bussolino F. The molecular action of tumor necrosis factor-alpha. Eur J Biochem. 202:1991;3-14.
31. Murphy HS, Shayman JA, Till GO, Mahrougui M, Owens CB, Ryan US, et al. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am J Physiol. 263:1992;L51-L59.
32. Warner BB, Stuart L, Gebb S, Wispe JR. Redox regulation of manganese superoxide dismutase. Am J Physiol. 271:1996;L150-L158.
33. Röhrdanz E, Kahl R. Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Radic Biol Med. 24:1998;27-38.
34. Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy. J Hepatol. 16:1992;380-383.
35. Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, et al. Neuronal-specific expression of human copperzinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res. 552:1991;198-214.
36. Amstad P, Moret R, Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem. 269:1994;1606-1609.
37. Peled-Kamar M, Lotem J, Okon E, Sachs L, Groner Y. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome. EMBO J. 14:1995;4985-4993.
38. Zhong W, Oberley LW, Oberley TD, Yan T, Domann FE, St. Clair DK. Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth Differ. 7:1996;1175-1186.
39. De-Haan JB, Wolvetang EJ, Cristiano F, Iannello R, Bladier C, Kelner M, et al. Reactive oxygen species and their contribution to pathology in Down syndrome. Adv Pharmacol. 38:1997;379-402.
40. Keller JN, Kindy MS, Holtsberg FW, St-Clair DK, Yen HC, Germeyer A, et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 18:1998;687-697.
41. Gopalakrishnan B, Shaha C. Inhibition of sperm glutathione S-transferase leads to functional impairment due to membrane damage. FEBS Lett. 422:1998;296-300.
42. Sompayrac L. SV40 and adenovirus may act as cocarcinogens by downregulating glutathione S-transferase expression. Virology. 233:1997;130-135.
43. Zhou T, Evans AA, London WT, Xia X, Zou H, Shen F, et al. Gluathione S-transferase expression in hepatitis B virus, associated human hepatocellular carcinogenesis. Cancer Res. 57:1997;2749-2753.
44. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 16:1992;637-641.
45. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 127:1997;423-428.
46. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 15:1994;7-10.